OC
URGN icon

Oppenheimer & Co’s UroGen Pharma URGN Stock Holding History

Oppenheimer & Co’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,962
Closed -$397K – 1791
2025
Q4 		$397K Buy
+16,962
New +$368K 0.01% 1160
2025
Q1 		– Sell
-11,875
Closed -$126K – 1666
2024
Q4 		$126K Buy
+11,875
New +$142K ﹤0.01% 1500
2024
Q3 		– Sell
-19,323
Closed -$324K – 1584
2024
Q2 		$324K Buy
+19,323
New +$275K 0.01% 1164
2023
Q2 		– Sell
-10,301
Closed -$95.2K – 1480
2023
Q1 		$95.2K Sell
10,301
-210
-2% -$1.93K ﹤0.01% 1321
2022
Q4 		$93.2K Buy
+10,511
New +$99.5K ﹤0.01% 1294
2020
Q3 		– Sell
-11,505
Closed -$301K – 1345
2020
Q2 		$301K Buy
+11,505
New +$281K 0.01% 969

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return